ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

0QSS Phaxiam Therapeutics

71.025
0.00 (0.00%)
02 Dec 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 4.14M3.36M4.45M5.28M3.72M4.18M6.65M1.33M
Operating Income -22.39M-30.89M-43.62M-64M-68.83M-56.52M-27.15M-23.37M
Pre Tax Income -21.9M-33.53M-38.22M-62.66M-73.3M-53.8M293k-23.7M
Net Income -21.91M-33.53M-38.22M-62.66M-73.3M-53.8M-228k-23.49M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -2.51-1.869-2.131-3.493-3.655-1.734-0.007-3.866
EBIT -22.39M-30.89M-43.62M-64.07M-68.83M-56.52M-27.15M-23.66M
EBITDA -21.96M-30.36M-42.82M-59.79M-63.84M-51.14M-22.53M-21.76M